ARTHRITIS

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ARTHRITIS
Generic name: MENTHOL
Manufacturer: Smith Amish, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 20c36972-b695-1241-e063-6394a90adf63
SPL ID: 45c89414-dd12-e304-e063-6294a90ae00d
Version: 6
Effective date: 2025-12-12
Source export date: 2026-10-27
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/a758d73d4d838a965005e6adf01b928e2da86f99be0f8bbaeeb95f3b7acbe418/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 19:57:51

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		ARTHRITIS	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		Smith Amish, LLC	openfda.manufacturer_name
ndc	package	72609-702-02	openfda.package_ndc
ndc	package	72609-702-04	openfda.package_ndc
ndc	product	72609-702	openfda.product_ndc
ndc11	package	72609070202	derived:openfda.package_ndc
ndc11	package	72609070204	derived:openfda.package_ndc
rxcui		416982	openfda.rxcui
spl id		45c89414-dd12-e304-e063-6294a90ae00d	id
spl set id		20c36972-b695-1241-e063-6394a90adf63	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Avoid contact with eyes If condition worsens, or if symptoms persist for more than 7 days or cler up and occur again within a few days,, discontinue use of this product and consult a doctor. If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.